
COURSE DIRECTORS

Mack Mitchell, MD
Vice President for Medical Affairs
University of Texas Southwestern
Medical Center
Dallas, Texas

Lawrence Schiller, MD
Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas
FACULTY WILL BE ANNOUNCED SOON!
AGENDA
Friday, May 15, 2026
11:00 AM
Lunch and Registration
11:30 AM - 12:15 PM
Industry-Sponsored Event (Non-accredited)
​
12:15 PM - 1:00 PM
Program Overview
Session I
1:00 PM - 1:25 PM
Gastric Premalignant Conditions ​
​
1:25 PM - 1:50 PM
Surveillance for Barrett’s Esophagus
​​​​
1:50 PM - 2:15 PM
Geriatrics in Gastroenterology​
2:15 PM - 2:30 PM
Q&A / Panel Discussion
2:30 PM – 2:45 PM
Break
Session II
​
2:45 PM - 3:10 PM
New and Emerging Treatments for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH)
​
​3:10 PM - 3:35 PM
NITs for Risk Stratification in Steatotic Liver Disease
​​
3:35 PM - 4:00 PM
Reducing Alcohol Use in Patients with Steatotic Liver Disease
​​​​​
4:00 PM - 4:15 PM
Q&A / Panel Discussion
​
4:15 PM - 4:45 PM
Break
​​​​
4:45 PM - 5:30 PM
Industry-Sponsored Event (Non-accredited)
​
5:30 PM - 7:00 PM
Reception
​
Saturday, May 16, 2026
​
7:00 AM
Breakfast and Registration
​
7:30 AM - 8:15 AM
Industry-Sponsored Event (Non-accredited)
​​​
8:15 AM – 8:45 AM
Break
8:45 AM - 8:50 AM
Program Overview
​
Session III
8:50 AM - 9:20 AM
What We Don’t Know About Celiac Disease
9:20 AM - 9:50 AM
Endoscopic Challenges with GLP-1 Agonists
9:50 AM - 10:20 AM
Latest Updates in Irritable Bowel Syndrome (IBS)
​​
​10:20 AM - 10:45 AM
Q&A / Panel Discussion
10:45 AM - 11:00 AM
Break
11:00 AM - 12:00 PM
Parallel Session (Select One)
-
GI Woes from Head to Toe
-
Inflammatory Bowel Disease
-
Obesity and Steatosis
-
Chronic Liver Disease
12:00 PM - 12:15 PM
Lunch Break
12:15 PM - 1:00 PM
Industry-Sponsored Event (Non-accredited)
​
Session IV
1:30 PM - 2:00 PM
Management of Obesity in 2026
​​
2:00 Pm - 2:30 PM
Diagnosis and Management of Hereditary Alpha-1 Antitrypsin (A1AT) Deficiency
​
2:30 PM - 2:55 PM
Management of Complications of Portal Hypertension Including Hepatic Encephalopathy and Ascites
​
2:55 PM - 3:20 PM
Screening and Management of Hepatocellular Carcinoma
3:20 PM - 3:35 PM
Q&A / Panel Discussion
3:35 PM - 3:45 PM
Break
Session V
3:45 PM - 4:15 PM
Positioning Therapies in Inflammatory Bowel Disease (IBD)
​​
4:15 PM - 4:45 PM
Managing the Pregnant Patient with IBD
4:45 PM - 5:15 PM
Preventative Care in IBD
5:15 PM - 5:30 PM
Q&A / Panel Discussion
5:30 PM - 5:40 PM
Meeting Wrap-up




